31Identification of over-expression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarrays analyses
Tsuda H, Ito YM, Ohashi Y, Wong KK, Hashiguchi Y, Welch WR, Berkowitz RS, Birrer MJ, Mok SCX
2005Clin Cancer Res 116880-6888
32Comparison of osteopontin expression in endometrioid endometrial cancer and ovarian endometrioid cancer
Hashiguchi Y, Tsuda H, Bandera CA, Nishimura S, Inoue T, Kawamura N, Mok SC
2006Medical Oncol 23205-212
33PTEN expression in clear cell adenocarcinoma of the ovary
Hashiguchi Y, Tsuda H, Berkowitz RS, Mok SC
2006Gynecologic Oncol 10171-75
34Endometrial thickness in Japanese women with hypertention or/and type2 diabetes mellitus
Nakamura H, Tsuda H, Hosoi M, Sato T, Inoue T, Nishimura S, Kawamura N
2006Eur J Obstet Gynecol RB
35Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staining
Takano M, Kikuchi Y, Yaegashi N, Kuzuya K, Ueki M, Tsuda H, Suzuki M, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Sugiyama T
2006Br J Cancer 941369-1374
36Clinical role of ABCF2 expression in breast cancer
Ogawa Y, Tsuda H, Hai E, Tsuji N, Yamagata S, Tokunaga S, Nakazawa K, Tamamori Y, Ogawa M, Shimizu S, Inoue T, Nishiguchi Y
2006Anti Cancer Res 231809-1814
37Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary
Takano M, Sugiyama T, Yaegashi N, Suzuki M, Tsuda H, Sagae S, Udagawa Y, Kuzuya K, Kigawa J, Takeuchi S, Tsuda H, Moriya T, Sugiyama T
2006Oncology Rep 161301-1306
38Phase II study of irinotecan plus doxorubicin for early recurrent （<12months） or platinum-refractory epithelial ovarian cancer. Interim analysis
Nishimura S, Tsuda H, Hashiguchi Y, Kokawa K, Nishimura R, Ishiko O, Kamiura S, Umesaki N
2007Int J Gynecol Cancer 17159-163
39Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer, and in clear cell adenocarcinomas of different organs
Nishimura S, Tsuda H, Ito K, Jobo T, Yaegashi N, Sudo T, Berkowitz RS, Mok SC
2007Human Pathol 38134-139
40Phase I trial of paclitaxel of paclitaxel, doxorubicin, and carboplatin （TAC） for the treatment of endometrial cancer
Shimada M, Kigawa J, Terakawa N, Yoshizaki A, Shoji T, Suzuki M, Hatae M, Tsuda H, Ohwada M, Sugiyama T
